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Abstract: Nosocomial pathogens are associated with increased hospital stay lengths and mortality
rates. Increasing resistance to antibiotics makes the treatment of these infections more difficult. Novel
antimicrobial compounds derived from natural sources may be useful for addressing antiobiotic resistance.
The objective of this study is to determine the chemical composition and antimicrobial activities of essential
oils from Myrtus communis L. (Myrtaceae) leaves against pathogens causing nosocomial infections. The
chemical composition of essential oil from M. communis leaves was analysed by gas chromatography-mass
spectrometry (GC-MS). The antimicrobial activity of the essential oil against bacteria and fungi was evaluated
by broth micro-dilution as per the Clinical and Laboratory Standards Institute (CLSI) methods. GC-MS analysis
revealed that the major constituents of the essential oil were α-pinene (39.2 %), 1,8-cineole (22.0 %), and
linalool (18.4 %). The essential oil exhibited antimicrobial activity against all Gram positive and Gram nega-
tive bacteria with MICs in the range of 0.5-32 μL/mL and 8-64 μL/mL, respectively. MICs for the tested
clinical and standard fungi were in the range of  0.03-16 μL/mL. The essential oil exhibited strong antibacte-
rial and antifungal activities against all the causative agents of nosocomial infections examined, particularly
against strains with antibiotic resistance. The essential oil from M. communis leaves is a potential source of
novel antimicrobial agents for the treatment of nosocomial infections.
Key words: Antifungal; antibacterial; minimum inhibitory concentration; Myrtus communis;
Candida, Myrtle.
Introduction
In recent years, pathogens causing nosocomial
infections have started to exhibit antiobiotic
resistance 4,12,16,29. Surveillance data reported by
the National Nosocomial Infection Surveillance
 shows that the distribution of pathogens causing
nosocomial infections varies with time and
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location 28. The top antiobiotic resistant pathogens
causing noso-comial infections include
methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin-resistant Enterococcus
strains, third-generation cephalosporin-resistant
Escherichia coli, imipenem and quinolone-
resistant Pseudomonas aeruginosa, and azole-
resistant Candida species 15,28.
In the face of increasing antibiotic resistance,
natural products and phytochemicals are being
examined as potential sources of novel
antimicrobial agents. A retrospective look at the
issue shows that plants have been, traditionally,
used to prevent and cure infectious diseases. They
synthesize aromatic chemicals and secondary
metabolites that serve as part of their defense
mechanisms against microbes. Myrtus communis
L. (Myrtaceae) is an evergreen shrub that grows
in Iran and many other countries. In folk medicine,
it has been used as an antiseptic, disinfectant and
hypoglycemic agent. Aqueous and methanolic
extracts from M. communis have proved effective
in dealing with cardiovascular disorders and
exhibited antimicrobial activities 3,14. Moreover,
different parts of the mentioned plant have been
used in both the cosmetic as well as food industry
as flavoring for meat and sauces. The leaves are
3-5 cm long with a pleasantly fragrant essential
oil that has known antifungal 25, antibacterial 27,30,
and antioxidant 32 activities. This study characte-
rizes the chemical components of the essential oil
from M. communis leaves collected from southern
Iran and screens its antimicrobial effects.
Materials and methods
Essential oil preparation
M. communis leaves were collected before
flowering stage from southern regions of Iran,
around Jahrom in the Fars province in May 2008.
The voucher specimen was identified by Dr. M.
Moein based on the morphological description
and known samples which collected previously
and deposited at the Herbarium of the Department
of Pharmacognosy, Faculty of Pharmacy, Shiraz
University of Medical Sciences, Iran (No. PM.2).
Briefly speaking, powder (300 g) from dried
M. communis leaves was distilled in water for 4 h
using a Clevenger-type apparatus (yield 0.69 %).
The yellow oil was dried over anhydrous sodium
sulphate, filtered, and stored at 4°C until analysis.
Essential oil analysis by Gas chromatography
Mass Spectrometry (GC-MS)
The essential oil obtained from the distillation
was analyzed by GC-MS (Helwett-Packared-
6890, Co., USA) using a capillary column (HP-
5MS, phenyl methyl silicon, 25 m × 0.25 mm, 1
μL injection). Helium was used as the carrier gas
(1.2 ml/min). The GC oven program was as
follows: initial temperature 50°C for 5 min,
programmed rate 3°C/min up to 200°C. The
injector temperature was 250°C. For MS
detection, an electron ionization system with
ionization energy of 70 eV was used. Injector and
MS transfer line temperatures were set at 250°C.
n-Alkanes were used to calculate Kovat´s Indices
(KI) for the detected compounds.
Tentative identification of the compounds was
based on the comparison of their relative retention
time and mass spectra with those from Wiley 275
and Adams data libraries for GC-MS 1.
Antimicrobial susceptibility testing
Fungal and microbial strains
Seven American Type Culture Collection
(ATCC) strains of fungi including Candida
albicans (ATCC 10261), C. tropicalis (ATCC
750), C. krusei (ATCC 6258), C. glabrata (ATCC
90030), C. parapsilosis (ATCC 4344),
Aspergillus flavus (ATCC 64025), and A.
fumigatus (ATCC 14110) were used in the
current study. In addition, the antimicrobial
activities of the essential oil against 39 strains
of yeasts, identified by PCR-RFLP 23,24 were
examined. Additionally included in the study is
determining in vitro activity of essential oil
against standard species of Staphylococcus
aureus (ATCC 25923 and ATCC 700698),
Entrococcus faecalis (ATCC11700),
Streptococcus pyogenes  (ATCC8668), S.
pneumonia (ATCC33400), Escherichia coli
(ATCC 25922), Pseudomonas aeruginosa
(ATCC 27853), Shigella flexneri (NCTC 8516),
Salmonella enterica subsp. enterica (ATCC
14028), and clinical isolates of S. aureus, E.
faecalis, E. faecium, E. coli, and P. aeruginosa.
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Determination of the antimicrobial activities
Using microdilution method according to the
CLSI guidelines 7,8,9, the antimicrobial activities
of the essential oil against above mentioned
microorganisms were determined. Briefly
speaking, in order to determine the antifungal
activities of the essential oil 7,8, serial dilutions of
the isolated essential oil (32.0 to 0.06 μL/mL)
were prepared in 96-well microtitre plates using
RPMI-1640 media (Sigma, St. Louis, USA)
buffered with MOPS (Sigma, St. Louis, USA).
Similarly, as to determine the antibacterial
activities 9, serial dilutions of the isolated essential
oil (0.25 to 128 μL/mL) were prepared in Muller-
Hinton media (Merck, Darmstadt, Germany) and
Tryptic soy broth (Merck, Darmstadt, Germany).
Test yeast or bacteria strains were suspended in
media and the cell densities were adjusted to 0.5
McFarland standards at 530 nm wavelength using
a spectrophotometeric method (this yields stock
suspension of 1-5 × 106 cells/ml for yeasts and 1-
1.5 × 108 cells/ml for bacteria). The working
inoculums (0.1 ml) were added to the micotiter
plates and the plates were incubated in a humid
atmosphere of 32°C for 24-48 h and 37°C for 24
h for the yeasts and bacteria, respectively.
Uninoculated medium (200 μL) was included as
a sterility control (blank). The growth controls
(medium with inoculums but without essential oil)
were also included. The growth in each well was
compared with that of the control growth well.
MICs of the tested micro-organisms were visually
read based on broth microdilution method as
recommended by CLSI 7,8,9. Each experiment was
performed in triplicate.
In addition, media from wells with fungi
showing no visible growth was further cultured
on sabouraud dextrose agar (Merck, Darmstadt,
Germany) and from wells with bacteria showing
no visible growth on tryptic soy agar (Merck,
Darmstadt, Germany) to determine the minimum
fungicidal concentration (MFC) and minimum
bactericidal concentration (MBC). MBCs and
MFCs were determined as the lowest concen-
tration yielding no more than 4 colonies, which
corresponds to a mortality of 98 % of the microbes
in the initial inoculums.
Oxacillin disks were used (Mast Diagnostics,
Merseyside, UK) for detection of methicillin
resistant S. aureus, vancomycin (Mast Diagnos-
tics, Merseyside, UK) for vancomycin resistant
Enterococci spp, ciprofloxacin and imipenem for
quinolone and imipeneme resistant P. aeruginosa
and ceftriaxone for third generation resistant E.
coli 10.
Results
Extraction of the essential oil from the M.
communis leaves produced a yellow essential oil
at 0.69 % yield. Approximately 24 compounds,
representing 97.1 % area of the oil, were identi-
fied. GC-MS analysis revealed that the major
constituents of the oil were α-pinene (39.2 %),
1,8-cineole (22.0 %), and linalool (18.4 %)  (Table
1). The oil was enriched with monoterpene
hydrocarbons (47.58 %) and oxygen-containing
monoterpenes (47.85 %). Sesquiterpenes and
oxygen-containing sesquiterpenes were detected
at 0.80 % area and 0.32 %, respectively.
The antibacterial activities of M. communis
essential oil are shown in Table 2. The essential
oil inhibited the growth of all Gram positive cocci
(MIC90) at  a concentration range  of  0.5-32 μL/
mL. Furthermore, the essential oil exhibited
bactericidal activity (MBC) for all Gram positive
cocci at concentrations ranging from 1 to 64 μL/
mL, except for one strain of Enterococci with an
MBC of 128 μL/mL.
The growth of all Gram negative bacteria was
inhibited by M. communis essential oil at the
concentration range  of 8-32 μL/mL (MIC), except
for Salmonella entrica (MIC 64 μL/mL). For
Gram negative bacteria, the MICs and MBCs were
the same for each given bacteria. No significant
differences in susceptibility to the essential oil
were found between antibiotic-resistant and
antibiotic-sensitive bacteria.
The antimicrobial activities of M. communis
essential oil against fungi are shown in Table 3.
For the clinical and standard yeasts tested, MICs
for the essential oil were in the range of 0.03-4
μL/mL, with isolates of C. glabrata
demonstrating the lowest MIC50 and MIC90
values (0.03 and 0.06 μL/mL, respectively). All
of the isolates showed MFC values of < 8 μL/
mL. The essential oil inhibited the growth of A.
fumigatus and A. flavus, with MIC50 values of 4
and 16 μL/mL, respectively.
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Table 1. Chemical composition of essential oil distilled from M. communis L. leaves
Compound KI a % (Peak area)  b
α-Pinene 940 39.2
δ-3-Caren 952 6.1
β-Phellandrene 980 0.1
Myrcene 993 0.1
Sabinene 1012 0.1
Limonene 1029 0.3
1,8-Cineole 1039 22.0
β-(z)Ocimene 1053 0.1
trans-Linalool oxide (furanoid) 1078 1.2
Terpinolene 1090 0.1
Linalool 1109 18.4
cis-Sabinene hydrate 1184 0.1
α-Terpineol 1204 2.2
Linalyl acetate 1264 3.6
Geraniol 1268 0.3
Thymol 1315 0.4
α-Terpinyl acetate 1354 0.6
Neryl acetate 1369 0.2
Geranyl acetate 1389 0.9
trans-Caryophyllene 1418 0.2
α-Humulene 1454 0.5
Flavesone 1544 0.1
Caryophyllene oxide 1581 0.1
Humulene epoxide II 1608 0.2
a Kovacs Indices to C9-C25 n-alkanes on the HP5MS column.
b The amount of each compound was calculated based on the total essential oil chromatogram area peak.
Table 2. Antibacterial activity (MIC and MBC) of
essential oil distilled from M. communis L.
Bacteria (Number of Strains) MIC 90 GMa MBC GMa
μL/mL (range) μL/mL (range)
Gram positive
Methicillin resistant S. aureus (MRSA) (6) 4 (4) 5.65 (4 - 8)
Methicillin sensitive S. aureus (MSSA) (6) 5.65 (4 - 8) 8 (8)
Vancomycin resistant E. feacalis (2) 11.31 (4 - 32) 45.2 (32 - 64)
Vancomycin sensitive E. feacalis (5) 14.25 (4 - 32) 64 (32 - 128)
Vancomycin resistant E.faecium (4) 27 (16 - 32) 107.63 (64 - 128)
S. mutans ATCC 35668 0.5 8
S. pneumonia ATCC 33400 0.5 4
S. pyogenes ATCC 8668 1 1
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         table 2. continued.
Bacteria (Number of Strains) MIC 90 GMa MBC GMa
μL/mL (range) μL/mL (range)
Gram negative
Third generation cephalosporin resistant E. coli (6) 27.85 (16 - 32) 27.85 (16 - 32)
Third generation cephalosporin sensitive E. coli (5) 25.4  (8 - 32) 25.4 (8 - 32)
Multidrug resistant P. aeruginosa (6) 14.25 (8 - 16) 14.25 (8 - 16)
Sensitive strain P. aeruginosa (5) 14.25 (8 - 16) 14.25 (8 - 16)
S. flexneri NCTC 8516 16 16
S. enterica ATCC 14028 64 64
a GM: Geometric Mean
Table 3. Antifungal activity (MIC and MFC) of essential oil distilled from M. communis L.
Essential Oil Fluconazole Itraconazole
M. communis (μL/mL)
Fungi (Number of Strains) MIC50 GM(Range) R > 64 μg/mLL R > 1 μg/mL
MIC90 GM(Range) SDD: 16-32 μg/mL SDD: 0.25-0.5 μg/mL
MFC GM(Range) S < 8 μg/m S < 0.12 μg/mL
C. albicans (19) 0.72 (0.25 - 2) 6 12
1.44 (0.5 - 4) 1 1
3.85 (0.5 - 8) 12 6
C. tropicalis (8) 0.53 (0.06 - 4) 3 3
1.07 (0.12 - 8) 2 3
3.08 (1 - 8) 3 2
C. dubliniensis (5) 0.32 (0.06 - 1) 0 0
0.65 (0.12 - 2) 0 0
1.74 (0.5 - 8) 5 5
C. glabrata (4) 0.34 (0.03 - 1) 0 0
0.69 (0.06 - 2) 0 1
1.39 (0.12 - 4) 4 3
C. parapsolosis (5) 0.75 (0.06 - 2) 0 0
1.50 (2 - 4) 0 2
2.63 (4 - 8) 5 3
C. guilliermondii (1) 1 0 0
2 0 1
4 1 0
C. krusei (1) 0.25 0 0
1 0 0
2 1 1
Aspergillus spp. (2) 8 (4 - 16) 0 0
- 0 0
- 2 2
GM: Geometric Mean; R: number of resistant strains
SDD: number of susceptible-dose dependent strains; S: number of susceptible strains
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Discussion
In the course of time, a number of studies have
been conducted investigating the chemical
composition of the essential oil from M. communis
leaves 6,18. Like that of Rasooli et al., 27 and
Messaoud et al., 22, α-pinene was determined as
the major constituent of the essential oil in the
recent study, while others have reported 1,8-
cineole 2,5,11,26,32 or myrtenyl acetate 13,17 as the
major constituent of the essential oil.
In the present study, M. communis essential oil
exhibited antimicrobial activities against a wide
number of microorganisms particularly those
antibiotic resistant strains responsible for
nosocomial infections. Consistent with previous
studies, the essential oil was active against both
methicillin resistant and sensitive S. aureus at
concentrations ranging from 4-8 μL/mL, 21,30,32.
In nosocomial infections, E. faecalis were
isolated more often than E. faecium. However, E.
faecium strains exhibited more resistance to
antibiotics than E. faecalis. Rasooli et al., found
no inhibitory effect of the essential oil against S.
aureus and E. faecalis by the agar diffusion
method 27. However, in this study, the essential
oil inhibited the growth of both E. faecalis and E.
faecium at  a concentration ranging from 4-32 μL/
mL. Moreover, the MICs and MBCs of
vancomycin resistant E. faecium were about three
times as much as those of vancomycin resistant
E. faecalis.
The MICs of M. communis essential oil for
Gram positive bacteria were lower than those for
Gram negative bacteria. These differences may
be due to the multi-layered cell membrane
structure and presence of lipopolysaccharide in
the cell membrane of Gram negative bacteria.
Moreover, the essential oil had both inhibitory and
bactericidal activities against all the examined
Gram negative bacteria with equal MICs and
MBCs. One of the Gram negative bacteria
examined, P. aeruginosa, is an opportunistic
bacteria with low susceptibility to many anti-
biotics 28. Rasooli et al., found no inhibitory effect
of the essential oil against P. aeruginosa 27.
However, in the present study, the essential oil
exhibited bacteri-cidal activity against P.
aeruginosa at a concen-tration ranging from 8-
16 μL/mL. This result is comparable with that of
the study conducted by Owlia et al., who reported
an MIC of 64 μg/mL against the same standard P.
aeruginosa strain 26.
Taking a contrastive look at the issue shows that
although some previous studies have reported that
the essential oil of M. communis had no inhibitory
effects against the growth of E. coli 14,30, others
have found that the growth of E. coli was inhibited
by the essential oil 18,27. The present study,
supporting the latter view, shows that the essential
oil exhibited bactericidal effects against both third
generation cephalosporins resistant (TGCsR) and
third generation cephalosporins sensitive
(TGCsS) E. coli at a concentration ranging from
8-32 μL/mL. The results of our study are, to some
extent, in line with that of the study by Rasooli et
al., who reported bacteriostatic (MIC 128 μL/mL)
and bacteriocidal (MBC 256 μL/mL) activities of
the essential oil against E. coli 27. The lower MICs
in the present study, as compared to Rasooli et
al., may be due to the difference in the oil consti-
tuents or the methods used to assay antimicrobial
activity 27. Unlike the present study, Rasooli et
al., used the agar diffusion test, which can be
affected by many factors such as interactions
between the test agent and agar, and/or reduced
permeability of the antimicrobial agent in agar.
Therefore, it is not recommended to use this meth-
od for determination of MIC of essential oils 20.
The proportion of nosocomial infections,
especially bloodstream infections, caused by
Candida species other than C. albicans is
increasing 16. The essential oil inhibited the growth
of all tested yeasts at a concentration ranging from
0.06 - 4 μL/mL. These results are consistent with
those of Yadegarnia et al., who reported the same
MIC (2 μL/mL) of M. communis essential oil for
C. albicans 32. In this study, M. communis essential
oil was fungicidal for C. albicans at 0.5-8 μL/
mL. Yadegarnia et al., reported a consistent value
of 4 μL/mL 32, while Rasooli et al., reported a
fungicidal activity at 128 μL/mL 27.
Mohammadi et al., reported that the essential
oil of M. communis had inhibitory effects on the
growth of Aspergillus species with MICs ranging
from 32-256 μL/mL. Lower MICs were
determined in the present study and may reflect a
Kamiar Zomorodian et al., / TEOP 16 (1) 2013 76 - 84 81
D
ow
nl
oa
de
d 
by
 [S
ha
hr
ek
or
d U
ni 
of
 M
ed
ica
l S
cie
nc
es
] a
t 2
2:1
1 1
9 D
ec
em
be
r 2
01
7 
difference in essential oil constituents or in the
antimicrobial determination methods 25.
α-Pinene has been previously reported to have
antimicrobial effects on Gram positive bacteria
with MICs values between 5 and 20 μL/mL 19.
Their MICs are almost the same as those
determined in this study except for the MICs of
Streptococci strains that were 5-10 times greater
than those determined in the present study. In this
study, the second major constituent identified in
the M. communis oil was 1,8-cineole exhibiting
antimicrobial activities with MICs ranging from
2-23 mg/mL like that of Van Vuuren and Viljoen
31. The fact that the whole essential oils have lower
MICs than the isolated constituents suggest that
there may be synergistic effects when the whole
essential oil is used. Many of the constituents of
the essential oil appear to have structures and
modes of action that are distinct from the
antibiotics tested here, suggesting that cross-
resistance with these antibiotics may be minimal.
Conclusions
Herbal remedies used in traditional folk medi-
cine may have a contribution in overcoming the
growing problem of microbial resistance to
antimicrobial agents. Taking the implication into
account, M. communis essential oil may be used
to develop novel antimicrobial agents on the basis
of the bactericidal and fungicidal activities of the
oil shown in this study as well as other works.
Further studies are, doubtlessly, needed to deter-
mine the efficacy of the active components of this
essential oil.
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